New Tool Helps Drug Developers Optimize Their Research and Target Development for Better Results and a Stronger Competitive Edge
FARMINGTON, Conn., June 4, 2012 /PRNewswire-iReach/ -- Global Information Inc is pleased to announce the immediate availability of a new report and new research tool for cancer drug research and development companies and market analysts:
Oncology Drug Pathway Analyzer
Drug targets and their pathways are the critical link between drugs and their role in the treatment of cancer. The Oncology Drug Pathway Analyzer from BioSeeker Group AB is an interactive data tool to analyze thousands drug-pathway connections in close to 90 different cancer indications. This tool allows users to examine both single pathways and crosstalk between pathways of drugs and filter the included drugs per pathway by twelve drug specific parameters (i.e. Indication, Stage, Company, Molecular function etc.).
With the Oncology Drug Pathway Analyzer, users can review their competition and find suitable benchmarking drugs, basing their search on specific pathways and drug properties. This will allow companies to uncover potential indication expansion areas for their drug portfolios, reveal repositioning opportunities for their older, shelved drugs, and evaluate the progression and success of targeting certain pathways for the treatment of cancer. This tool will also help users investigate different therapy combination options available for various cancer types, and reveal for the most-efficient ways to combine their drugs with other targeted agents.
A detailed description of the tool and a real case scenario are available at http://www.giiresearch.com/report/bg243231-oncology-drug-pathway-analyzer-premium-version.html
Cancer Treatment Drugs Markets in China
As China's continued rise as a modern economy proves to be a significant growth sector, demand for cancer treatment drugs across their nation has grown at a quick pace over the past decade, with both production and demand forecast to continue to this steady growth in the next five years.
Now, Global Information is pleased to make available a collection of 12 complete cancer drug market research reports from Asia Market Information & Development on the Chinese Cancer treatment drugs market, covering the following cancers: lung cancer, breast cancer, prostate cancer, leukemia, ovrian cancer, colon cancer, cevical cancer, brain cancer, bladder cancer, liver cancer, kidney cancer, and skin cancer treatment drugs.
The reports include market trends, developments, with market forecasts through 2016 and 2021.
A summary for this report and a free sample of the full document are available at http://www.giiresearch.com/report/amid243405-cancer-treatment-drugs-markets-china-12-full.html
About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.
SOURCE Global Information, Inc.Back to top